Customized research for NAVB vs. ACOR!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for NAVB vs. ACOR.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Navidea Biopharmaceuticals, Inc vs. Acorda Therapeutics, Inc.

Industry Match! Industry of Both NAVB and ACOR:

Health Care/Life Sciences

NAVB
Data Last Updated: 2 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 52.598M


P/E: N/A

P/S: 79.69

Q P/B: N/A

Y Rev: 657,826

Q Rev: 156,272

Beta: 1.14

NAVB Share Stats

Outstanding Shares

21.65M

Float Shares

14.26M

Percent of Float Short

3.73%

NAVB Insider Stats

Percent Outstanding Insider Ownership

98.79%

Percent Outstanding Institution Ownership

3.32%

NAVB Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

NAVB in Pulse Portal

Stream of Posts

NAVB Symbol Page

Share NAVB Insights

Express Sentiment

'Buy' or 'Sell' NAVB

NAVB Profile

CEO

Mr. Jed Andrew Latkin

Exchange

NYSE American

Employees

17.00

About

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is...

NAVB Financials

Annual Financials

Income Statement

Revenue

657,826

Net Income

(10.95M)

Cash Flow Statement

Change in Cash / Investments

(2.43M)

Balance Sheet

Cash / Investments

1.05M

Short Term Debt

556,508

Long Term Debt

None

Total Current Assets

2.92M

Total Current Liabilities

3.82M

Total Assets

4.15M

Total Liabilities

5.03M

Stockholder Equity

(1.61M)

Quarterly Financials

Income Statement

Q Revenue

156,272

Q Net Income

(2.67M)

Cash Flow Statement

Q Change in Cash / Investments

(445,804)

Balance Sheet

Q Cash / Investments

601,355

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

3.45M

Q Total Current Liabilities

4.35M

Q Total Assets

5.39M

Q Total Liabilities

5.57M

Q Stockholder Equity

(909,844)

NAVB Charts

10-Year Chart

NAVB 10-Year Chart

5-Year Chart

NAVB 5-Year Chart

1-Year Chart

NAVB 1-Year Chart

6-Month Chart

NAVB 6-Month Chart

3-Month Chart

NAVB 3-Month Chart

1-Month Chart

NAVB 1-Month Chart

1-Day Chart

NAVB 1-Day Chart

ACOR
Data Last Updated: More than 2 wks ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 35.509M


P/E: N/A

P/S: 0.18

Q P/B: 0.12

Y Rev: 192.41M

Q Rev: 28.1M

Beta: 1.62

ACOR Share Stats

Outstanding Shares

47.98M

Float Shares

47.19M

Percent of Float Short

30.08%

ACOR Insider Stats

Percent Outstanding Insider Ownership

2.35%

Percent Outstanding Institution Ownership

57.4%

ACOR Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ACOR in Pulse Portal

Stream of Posts

ACOR Symbol Page

Share ACOR Insights

Express Sentiment

'Buy' or 'Sell' ACOR

ACOR Profile

CEO

Dr. Ronald Cohen

Exchange

Nasdaq

Employees

344.00

About

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22,...

ACOR Financials

Annual Financials

Income Statement

Revenue

192.41M

Net Income

(272.97M)

Cash Flow Statement

Change in Cash / Investments

(189.16M)

Balance Sheet

Cash / Investments

138.68M

Short Term Debt

7.75M

Long Term Debt

231.83M

Total Current Assets

201.11M

Total Current Liabilities

86.39M

Total Assets

899.76M

Total Liabilities

588.94M

Stockholder Equity

310.82M

Quarterly Financials

Income Statement

Q Revenue

28.1M

Q Net Income

(6.47M)

Cash Flow Statement

Q Change in Cash / Investments

(14.97M)

Balance Sheet

Q Cash / Investments

96.07M

Q Short Term Debt

7.85M

Q Long Term Debt

231.03M

Q Total Current Assets

168.29M

Q Total Current Liabilities

70.63M

Q Total Assets

753.83M

Q Total Liabilities

447.15M

Q Stockholder Equity

306.67M

ACOR Charts

10-Year Chart

ACOR 10-Year Chart

5-Year Chart

ACOR 5-Year Chart

1-Year Chart

ACOR 1-Year Chart

6-Month Chart

ACOR 6-Month Chart

3-Month Chart

ACOR 3-Month Chart

1-Month Chart

ACOR 1-Month Chart

1-Day Chart

ACOR 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon